2
Registered trials
0
Recruiting
2
Unique sponsors
2
Unique IMPs
2
Commercial trials
Drug classes (ATC)
—
ATC code not specified
1
N
Neurology/Psychiatry (ATC N)
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
2 substances
Phase II:
1
Phase I (Other):
1
Phase II
1 trial-
EndediN Therapeutics Co. Ltd. CommercialANERATRIGINE MESILATE; TRAMADOL HYDROCHLORIDE, PARACETAMOL
Phase I (Other)
1 trial-
EndedIBSA Institut Biochimique SA CommercialIMP not specified
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| IBSA Institut Biochimique SA | Commercial | 1 | Phase I (Other) | 0 |
| iN Therapeutics Co. Ltd. | Commercial | 1 | Phase II | 0 |
New trials by year
2025
1